Trial Profile
Chindamide in Combination With Lenalidomide and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma, a Phase II Trial
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Aug 2022
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Dexamethasone (Primary) ; Lenalidomide (Primary) ; Tucidinostat (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 03 Aug 2018 New trial record